• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 3896

10-year publication summary

119
225
351
433
391
434
419
404
384
303
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
437
89
Hanmi Pharm. Co., Ltd.
576
71
The Regents of the University of California
20245
61
Bristol-myers Squibb Company
4833
47
Ascendis Pharma A/S
184
44
The Johns Hopkins University
5746
42
Massachusetts Institute of Technology
10124
40
Ascendis Pharma Growth Disorders A/S
57
39
Synthorx, Inc.
82
35
Board of Regents, The University of Texas System
5921
34
Ascendis Pharma Bone Diseases A/S
48
27
Amgen Inc.
4161
26
Quiapeg Pharmaceuticals AB
45
26
Janssen Pharmaceutica N.V.
3351
24
NOK Corporation
2237
23
The Board of Trustees of the Leland Stanford Junior University
6522
22
Northwestern University
3444
22
SeaGen Inc
594
21
Ambrx, Inc.
180
20
Yale University
2436
20
Other owners 3163